Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Clinical trial NCT01811992 · COMPLETED

Trial details

NCT number: NCT01811992
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma Multiforme

Start date: 2014-04-01
Primary completion: 2019-02-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.